申请人:Teijin Pharma Limited
公开号:EP1826207A1
公开(公告)日:2007-08-29
The present invention provides acid salts, such as sulfate, hydrochloride, and methanesulfonate, of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid and the crystals thereof. These benzimidazole derivatives and the crystals thereof have an in vivo chymase inhibitory activity and can be used as a preventive or therapeutic agent for inflammatory diseases, allergic diseases, respiratory diseases, circulatory diseases, or bone/cartilage metabolic diseases.
本发明提供了4-(1-((4-甲基苯并噻吩-3-基)甲基)苯并咪唑-2-硫基)丁酸及其晶体的酸盐,如硫酸盐、盐酸盐和甲磺酸盐。这些苯并咪唑衍生物及其晶体具有体内糜蛋白酶抑制活性,可用作炎症性疾病、过敏性疾病、呼吸系统疾病、循环系统疾病或骨/软骨代谢疾病的预防或治疗剂。